Avoiding false discoveries: Revisiting an Alzheimer's disease snRNA-Seq dataset
Murphy, A. E.; Fancy, N.; Skene, N. G.
Show abstract
Mathys et al., conducted the first single-nucleus RNA-Seq study (snRNA-Seq) of Alzheimers disease (AD)1. The authors profiled the transcriptomes of approximately 80,000 cells from the prefrontal cortex, collected from 48 individuals - 24 of which presented with varying degrees of AD pathology. With bulk RNA-Seq, changes in gene expression across cell types can be lost, potentially masking the differentially expressed genes (DEGs) across different cell types. Through the use of single-cell techniques, the authors benefitted from increased resolution with the potential to uncover cell type-specific DEGs in AD for the first time2. However, there were limitations in both their data processing and quality control and their differential expression analysis. Here, we correct these issues and use best-practice approaches to snRNA-Seq differential expression, resulting 549 times fewer differentially expressed genes at a false discovery rate (FDR) of 0.05.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genome-Wide Association Study of Brain Connectivity Changes for Alzheimer's Disease 92%
- Identifying cellular markers of focal cortical dysplasia type II with cell-type deconvolution and single-cell signatures 91%
- Co-localized SNPs Affecting the Expression of Taste Perception Genes are linked to Alzheimer's Disease 91%
Similar papers in this journal
- Large-Scale Deep Multi-Layer Analysis of Alzheimer's Disease Brain Reveals Strong Proteomic Disease-Related Changes Not Observed at the RNA Level 90%
- Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis 90%
- Stem cell derived human microglia transplanted in mouse brain to study genetic risk of Alzheimer's Disease 89%
Similar papers in this journal
- A meta-analysis of epigenome-wide association studies in Alzheimer's disease highlights novel differentially methylated loci across cortex 92%
- Molecular Signatures of Resilience to Alzheimer's Disease in Neocortical Layer 4 Neurons 92%
- Human-lineage-specific genomic elements: relevance to neurodegenerative disease and APOE transcript usage 92%
Similar papers in this journal
- Machine learning-based prediction of cognitive outcomes in de novo Parkinson’s disease 92%
- Epigenetic insights into neuropsychiatric and cognitive symptoms in Parkinson's disease: A DNA co-methylation network analysis 91%
- Local genetic correlations exist among neurodegenerative and neuropsychiatric diseases 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.